ESC 365 - Women in cardiology leadership of randomized clinical trials and participation of women in late-breaking clinical trials: has the COVID-19 pandemic changed a thing or not exactly?

ESC Professional Premium Access

Women in cardiology leadership of randomized clinical trials and participation of women in late-breaking clinical trials: has the COVID-19 pandemic changed a thing or not exactly?

Session: Cardiovascular disease in women 2

Topic: Cardiovascular Disease in Women

Speaker: Assistant Professor B. Parapid (Belgrade, RS)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Assistant Professor Biljana Parapid

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

0 follower

4 more presentations in this session

Sex differences in management and in-hospital outcomes in patients presenting with cardiogenic shock in a coronary care unit from a low to middle income country

Speaker: Doctor M. Villalobos-Pedroza (Mexico City, MX)

The interplay of sex-specific electrophysiology and repolarization heterogeneity governs ventricular arrhythmia sustainability in women

Speaker: Doctor V. Sobota (Bordeaux, FR)

Evaluation of cardiovascular disease in the turner syndrome population in Northern Ireland

Speaker: Doctor A. Kearney (Belfast, GB)

Women with cardiogenic shock: risk factors and management in a tertiary center.

Speaker: Doctor B. Diaz Arroyo (Ciudad de Mexico, MX)

Access the full session

Cardiovascular disease in women 2

Speakers: Assistant Professor B. Parapid, Doctor M. Villalobos-Pedroza, Doctor V. Sobota, Doctor A. Kearney, Doctor B. Diaz Arroyo

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources